Tryptophan-Rich Short Peptide Amphiphile-Mediated Synthesis of Silver Nanoparticles for Potent Antibacterial Applications
Abstract
This study introduces a simple, eco-friendly, and biocompatible method for synthesizing hybrid antibacterial nanostructures using tryptophan-rich short peptide amphiphile (sPA). This sPA serve a dual role as both reducing and stabilizing agent for silver nanoparticles (AgNPs). Designed with self-assembling capabilities, the sPA spontaneously form polydispersed heterogeneous supramolecular nanostructures and simultaneously enable the in situ photoreduction of Ag(I) ions under mild sunlight exposure, owing to the intrinsic photophysical and redox-active properties of tryptophan residues. The resulting AgNP-sPA hybrids display well-defined polydispersed morphologies, confirmed through detailed spectroscopic and microscopic analyses. These nanoconjugates show excellent colloidal stability and strong interactions with bacterial membranes. Antibacterial assessments reveal that the AgNP-sPA hybrids exhibit potent and broad-spectrum activity against both Gram-positive (e.g., Staphylococcus aureus) and Gram-negative pathogens, including Escherichia coli (standard and clinical strains), Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Notably, the hybrids demonstrate superior efficacy compared to the conventional antibiotic levofloxacin. Importantly, the AgNP-sPA nanostructures also exhibit significant inhibitory activity against multidrug-resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Staphylococcus…
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.